Eledon Pharmaceuticals, Inc. (ELDN) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

Corporate company logo of Eledon Pharmaceuticals Inc. (ELDN)

Eledon Pharmaceuticals (ELDN) is optimizing clinical trials of immune molecules through partnerships with contract research organizations while maintaining full control over its intellectual property. The company is developing the tegoprubart antibody to protect organs from rejection without the use of hazardous steroids. As confirmed by the price history on the chart, the EV/EBITDA dynamics stand at 0.00, linking financial performance to the development of a safe transplantation ecosystem that ensures patient longevity and health.

ELDN Eledon Pharmaceuticals, Inc: Enterprise Value to EBITDA Ratio in the range 11/23/2025 - 11/13/2026

eledon.com - analytical breakdowns and key metrics (ELDN)

- current price and projected stock value:
Initial company analysis:Eledon ELDN
Original product of eledon.com

For Eledon Pharmaceuticals (ELDN), operating in the highly competitive transplantation segment, this indicator determines the real value of the business relative to its operating profit. The ratio compares market capitalization, adjusted for net debt, against EBITDA, revealing risks of excessive leverage. Analysis using the EV/EBITDA multiple allows for tracking the impact of market volatility on the company's creditworthiness. This is critically important, as pressure from biotech behemoths could sharply alter the asset's investment attractiveness.

Competitor analysis

EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio BioNTech Pharma (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|admabiologics.com (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant Inc|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple Grifols Biemat|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies (ADPT)|celldex.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUPH (Aurinia Pharmaceuticals Inc.)|BioCryst Pharmaceuticals, Inc. (BCRX) - Company Value to EBITDA|Vera Pharma - EV/EBITDA Multiple|Company Value to EBITDA Dianthus Corp|Pharvaris N.V. (PHVS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ABCL (AbCellera) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TRML (Tourmaline Bio) - EV/EBITDA Multiple|Company Value to EBITDA Precigen Inc PGEN|EV/EBITDA Multiple PHAR|Nektar Corp - Enterprise Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Upstream Bio Inc UPB|zenasbio.com (ZBIO) - Company Value to EBITDA|IMNM - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|GOSS (Gossamer Bio Inc) - Enterprise Value to Operating Income Before Depreciation|KALV (KalVista Pharmaceuticals Inc) - Enterprise Value to EBITDA Ratio|Septerna Pharma - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pieris Pharmaceuticals|savarapharma.com - Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple RIGL|ANAB (AnaptysBio Inc) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple ATXS (Astria Pharma)|EV/EBITDA Multiple enGene Corp ENGN|RAPT - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation JBIO (Aerovate Therapeutics Inc)|Aclaris Therapeutics, Inc. (ACRS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Kyverna Therapeutics Inc.|TLSA (Tiziana Life Sciences PLC) - EV/EBITDA Multiple|EV/EBITDA Multiple Cabaletta Bio Inc|EV/EBITDA Multiple VTYX|Enterprise Value to EBITDA Ratio theratech.com THTX|EV/EBITDA Multiple AVTX (Avalo Therapeutics)|Agenus, Inc. (AGEN) - Company Value to EBITDA|CLYM: Enterprise Value to EBITDA Ratio|ZURA - EV/EBITDA Multiple|ATYR (aTyr Pharma, Inc.) - Enterprise Value to EBITDA Ratio|ADAG: Enterprise Value to Operating Income Before Depreciation Ratio|IMA (ImageneBio) - EV/EBITDA Multiple|Shattuck Therapeutics (STTK) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple EQ|Enterprise Value to EBITDA Ratio connectbiopharm.com CNTB|EV/EBITDA Multiple IMUX (Immunic)|EV/EBITDA Multiple Atara Biotherapeutics, Inc. ATRA|IFRX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|XFOR: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|adicetbio.com (ACET) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|CELU - Total Company Value to Operating Income Before Depreciation Ratio|INMB (INmune Bio, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA barinthusbio.com BRNS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Kezar Life Sciences, Inc. (KZR)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization SABS (SAB Biotherapeutics Inc.)|EV/EBITDA Multiple AKTX (Akari Therapeutics plc)|ENLV: Enterprise Value to Operating Income Before Depreciation|QTTB - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|GOVX (geovax.com) - Enterprise Value to Operating Income Before Depreciation|Edesa Biotech (EDSA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio IBIO (iBio Inc)|CARM (Carisma Therapeutics Inc) - EV/EBITDA Multiple|XTLB: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple BOLT|EV/EBITDA Multiple hcwbiologics.com (HCWB)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Aptevo Therapeutics Inc. APVO|Business Value to Operating Income Before Depreciation AIM|ADTX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|GRI Bio Corporation (GRI) - Enterprise Value to EBITDA Ratio|XRTX: EV/EBITDA Multiple|reshapelifesciences.com (HIND) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio REVB|INDP: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple SCNI|Total Company Value to Operating Income Before Depreciation Ratio calcimedica.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Affimed N.V. AFMD|ALLK - Enterprise Value to EBITDA Ratio|HOOK - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|IGM Biosciences, Inc. (IGMS) - Enterprise Value to EBITDA Ratio|ITOS (iTeos) - Enterprise Value to EBITDA Ratio|Ocean Biomedical Corp (OCEA) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization TC Biopharm|Enterprise Value to Operating Income Before Depreciation THRD (thirdharmonicbio.com)